1. Home
  2. NRSN vs QRHC Comparison

NRSN vs QRHC Comparison

Compare NRSN & QRHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRSN
  • QRHC
  • Stock Information
  • Founded
  • NRSN 2017
  • QRHC N/A
  • Country
  • NRSN Israel
  • QRHC United States
  • Employees
  • NRSN N/A
  • QRHC N/A
  • Industry
  • NRSN Biotechnology: Pharmaceutical Preparations
  • QRHC Environmental Services
  • Sector
  • NRSN Health Care
  • QRHC Utilities
  • Exchange
  • NRSN Nasdaq
  • QRHC Nasdaq
  • Market Cap
  • NRSN 31.1M
  • QRHC 32.3M
  • IPO Year
  • NRSN 2021
  • QRHC N/A
  • Fundamental
  • Price
  • NRSN $1.22
  • QRHC $1.42
  • Analyst Decision
  • NRSN Buy
  • QRHC
  • Analyst Count
  • NRSN 2
  • QRHC 0
  • Target Price
  • NRSN $14.00
  • QRHC N/A
  • AVG Volume (30 Days)
  • NRSN 404.8K
  • QRHC 65.1K
  • Earning Date
  • NRSN 09-17-2025
  • QRHC 11-06-2025
  • Dividend Yield
  • NRSN N/A
  • QRHC N/A
  • EPS Growth
  • NRSN N/A
  • QRHC N/A
  • EPS
  • NRSN N/A
  • QRHC N/A
  • Revenue
  • NRSN N/A
  • QRHC $270,706,000.00
  • Revenue This Year
  • NRSN N/A
  • QRHC N/A
  • Revenue Next Year
  • NRSN N/A
  • QRHC $4.24
  • P/E Ratio
  • NRSN N/A
  • QRHC N/A
  • Revenue Growth
  • NRSN N/A
  • QRHC N/A
  • 52 Week Low
  • NRSN $0.80
  • QRHC $1.41
  • 52 Week High
  • NRSN $2.60
  • QRHC $8.52
  • Technical
  • Relative Strength Index (RSI)
  • NRSN 44.56
  • QRHC N/A
  • Support Level
  • NRSN $1.12
  • QRHC N/A
  • Resistance Level
  • NRSN $1.26
  • QRHC N/A
  • Average True Range (ATR)
  • NRSN 0.06
  • QRHC 0.00
  • MACD
  • NRSN 0.01
  • QRHC 0.00
  • Stochastic Oscillator
  • NRSN 36.87
  • QRHC 0.00

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

About QRHC Quest Resource Holding Corporation

Quest Resource Holding Corp is a national provider of waste and recycling services to customers from across multiple industry sectors that are typically larger, multi-location businesses. The company creates customer-specific programs and perform the related services for the collection, processing, recycling, disposal, and tracking of waste streams and recyclables. The company's services focus on the waste streams and recyclables from box, grocers, and other specialty retailers; automotive after-market operations such as automotive maintenance, quick lube, dealerships, and collision repair; transportation, logistics, and fleet operators; manufacturing and industrial facilities; multi-family and commercial properties; restaurant chains and food operations, etc.

Share on Social Networks: